Health Care & Life Sciences » Pharmaceuticals | Intellipharmaceutics International Inc.

Intellipharmaceutics International Inc.

Intellipharmaceutics International Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
43.54 M
Public Float
-
Intellipharmaceutics International Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.32
Market Cap
$15.4 M
Shares Outstanding
43.54 M
Public Float
-

Profile

Address
30 Worcester Road
Toronto Ontario M9W 5X2
Canada
Employees -
Website http://www.intellipharmaceutics.com
Updated 09/14/2018
Intellipharmaceutics International, Inc. is a pharmaceutical company, which engages in the research, development, and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to the development of existing and new pharmaceuticals in the areas of neurology, cardiovascular, gastrointestinal tract, diabetes and pain. The company was founded by Isa Odidi and Amina Odidi on October 22, 2009 and is headquartered in Toronto, Canada.

Financials

View All

Amina Odidi
President, Chief Operating Officer & Director
Shawn Graham
Independent Director